HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
Globe Newswire (Thu, 27-Aug 8:00 AM ET)
HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule
Globe Newswire (Mon, 3-Aug 4:00 PM ET)
HealthEquity Delivers 29% EPS Growth and Strong HSA Asset Expansion—Adjusted EBITDA Margin Hits 44%
Market Chameleon (Thu, 4-Dec 6:19 AM ET)
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Healthequity trades on the NASDAQ stock market under the symbol HQY.
As of September 16, 2026, HQY stock price declined to $96.00 with 632,400 million shares trading.
HQY has a beta of 0.43, meaning it tends to be less sensitive to market movements. HQY has a correlation of 0.02 to the broad based SPY ETF.
HQY has a market cap of $7.94 billion. This is considered a Mid Cap stock.
Last quarter Healthequity reported $351 million in Revenue and $1.24 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.09.
In the last 3 years, HQY traded as high as $116.65 and as low as $61.81.
The top ETF exchange traded funds that HQY belongs to (by Net Assets): VTI, VB, VBK, VXF, MDY.
HQY has underperformed the market in the last year with a price return of +3.2% while the SPY ETF gained +15.2%. However, in the short term, HQY had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.4% vs +0.1% return in SPY. But in the last 2 weeks, HQY shares have been beat by the market, returning -1.0% compared to an SPY return of -1.0%.
HQY support price is $94.87 and resistance is $98.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HQY shares will trade within this expected range on the day.